Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The SWIR Otoscopy Study is a clinical trial designed to see if a new type of ear examination tool, called a short wave infrared (SWIR) otoscope, is better than a traditional white light otoscope for diagnosing middle ear infections, also known as otitis media. This study will involve children aged 1 to 17 who are visiting the Ear, Nose, and Throat Clinic at Lucile Packard Children's Hospital to have a procedure called tympanostomy tube placement. During the procedure, both types of otoscopes will be used to check for fluid in the middle ear, and the results will help determine if the new tool is more effective.
To participate in this study, children must be between the ages of 1 and 17 and scheduled for the tympanostomy tube placement at the clinic. Their parents or guardians will need to understand and agree to the study by signing a consent form. The study is not yet recruiting, so participants will be informed about the process and what to expect when the study begins. Overall, this research aims to improve how doctors diagnose ear infections, which can help children get the right treatment more quickly.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ages 1-17
- • Being seen in the Ear, Nose, and Throat Clinic at Lucile Packard Childrens Hospital
- • Undergoing tympanostomy tube placement as part of standard of care
- • Parents and/or patient has the ability to understand and the willingness to sign a written informed consent form or assent form.
- Exclusion Criteria:
- • Patients under 1 year of age or 18 and older
- • Participants not meeting the inclusion criteria
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Washington Dc, District Of Columbia, United States
Patients applied
Trial Officials
Tulio Valdez, MD, MSc
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported